Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Investors Business Daily
Investors Business Daily
Business
MATT KRANTZ

Analysts Say 9 Stocks Will Pay Off If You 'Buy The Dip'

Savvy investors know that buying leading growth stocks is the best way to profit long term. But right now, there's a rush to buy the dip in the S&P 500.

Analysts say nine beaten-down S&P 500 stocks, including Moderna, UnitedHealth and Halliburton, stand to rocket 30% or more in 12 months, says an Investor's Business Daily analysis of data from S&P Global Market Intelligence and MarketSurge. All these stocks are still down 20% or more this year.

Now that President Donald Trump is backing away from tariffs, many investors are looking for opportunities again. "The larger-than-expected drop in the tariffs between the U.S. and China, while temporary, and the establishment of a framework for continued discussion, is exactly what the stock market was hoping to see, said Carol Schleif, chief market strategist, BMO Private Wealth.

Looking For Big Biotech Wins In The S&P 500

Moderna, a maker of high tech vaccines, is the buy-the-dip darling. Shares are down a punishing 38% this year to 24.70. And yet, analysts remain bullish. They think the stock will trade for 46.96 in 12 months. If that's right, it's a gain of nearly 83%.

It's definitely a long shot based on the charts. The RS Rating is just 6. And analysts think earnings will fall 9% this year.

In another health care play, analysts think insurer UnitedHealth will gain 45% in 12 months. The shares are down 25% this year. It's another buy and a prayer stock. The RS Rating is just 11. And analysts think earnings will fall 5% this year.

Again, it can't be stressed enough that the top S&P 500 stocks over time are the leaders. But if you're going to risk it and buy the dip, these are the plays analysts like most.

Analysts' 'Buy The Dip' Favorites

All down 20% or more this year, seen jumping 30%-plus in 12 months

Company Ticker YTD % Ch. Sector Implied Upside
Moderna MRNA -38.2% Health Care 82.7%
UnitedHealth Group UNH -25.1% Health Care 44.6%
Alexandria Real Estate Equities ARE -23.9% Real Estate 44.5%
Halliburton HAL -21.8% Energy 38.1%
Albemarle ALB -28.5% Materials 35.1%
Norwegian Cruise Line NCLH -25.6% Consumer Discretionary 32.2%
Viatris VTRS -28.0% Health Care 31.1%
Deckers Outdoor DECK -37.9% Consumer Discretionary 30.1%
Bio-Techne TECH -25.2% Health Care 30.1%
Sources: S&P Global Market Intelligence, IBD
Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.